13F-HR filed by Broadfin Capital, LLC
Broadfin Capital, LLC filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 85 holding rows worth $1,032,271,000.
- Accession
- 0000919574-14-003378
- Filer
- CIK 1511901
- Filed
- 2014-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2014
A holdings report, 85 entries on the cover page, a total value of $1,032,271,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,032,271,000 with VALUE read as thousands by filing date, 13F file number 028-14251. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBroadfin Healthcare Master Fund Ltd028-14254
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| FLAMEL TECHNOLOGIES-SP ADR | 338488109 | SPON | 5,267,911 | $70,590,000 | thousands by filing date | |
| HORIZON PHARMA INC | 44047T109 | COM | 4,305,469 | $65,099,000 | thousands by filing date | |
| DEPOMED INC | 249908104 | COM | 3,190,816 | $46,267,000 | thousands by filing date | |
| EMERGENT BIOSOLUTIONS INC | 29089Q105 | COM | 1,805,352 | $45,621,000 | thousands by filing date | |
| ANGIODYNAMICS INC | 03475V101 | COM | 2,592,649 | $40,834,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 1,609,696 | $34,126,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 2,233,173 | $31,063,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 3,472,054 | $29,304,000 | thousands by filing date | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 1,226,617 | $27,329,000 | thousands by filing date | |
| LANNETT COMPANY INCORPORATED | 516012101 | COM | 683,564 | $24,417,000 | thousands by filing date | |
| PROGENICS PHARMACEUTICALS IN | 743187106 | COM | 5,586,169 | $22,847,000 | thousands by filing date | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 2,008,125 | $21,868,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 1,669,777 | $21,173,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 5,455,119 | $21,166,000 | thousands by filing date | |
| CATAMARAN CORP | 148887102 | COM | 468,263 | $20,959,000 | thousands by filing date | |
| ANACOR PHARMACEUTICALS INC | 032420101 | COM | 1,000,869 | $20,027,000 | thousands by filing date | |
| NATUS MEDICAL INC | 639050103 | COM | 764,915 | $19,735,000 | thousands by filing date | |
| DISCOVERY LABORATORIES INC N | 254668403 | COM NEW | 8,066,000 | $17,342,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 867,117 | $16,779,000 | thousands by filing date | |
| IMPAX LABORATORIES INC | 45256B101 | COM | 633,929 | $16,748,000 | thousands by filing date | |
| AEGERION PHARMACEUTICALS INC | 00767E102 | COM | 350,000 | $16,163,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 1,326,000 | $15,766,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 291,636 | $15,410,000 | thousands by filing date | |
| PERNIX THERAPEUTICS HOLDINGS | 71426V108 | COM | 3,500,000 | $14,980,000 | thousands by filing date | |
| ZOGENIX INC | 98978L105 | COM | 5,137,645 | $14,617,000 | thousands by filing date | |
| SESEN BIO, INC. | 286221106 | COM | 861,933 | $13,989,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158102 | COM | 7,660,100 | $13,846,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 712,495 | $13,402,000 | thousands by filing date | |
| IDERA PHARMACEUTICALS INC | 45168K306 | COM | 3,200,700 | $13,059,000 | thousands by filing date | |
| SYNERON MEDICAL LTD | M87245102 | ORD | 1,005,221 | $12,515,000 | thousands by filing date | |
| ARATANA THERAPEUTICS INC | 03874P101 | COM | 667,435 | $12,388,000 | thousands by filing date | |
| LIBERATOR MEDICAL HLDGS INC | 53012L108 | COM | 3,058,644 | $12,020,000 | thousands by filing date | |
| AUXILIUM PHARMACEUTICALS | 05334D107 | COMMON STOCK | 411,100 | $11,174,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 955,147 | $11,032,000 | thousands by filing date | |
| OMNICARE INC | 681904108 | COM | 175,000 | $10,442,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 275,000 | $10,329,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 774,881 | $9,089,000 | thousands by filing date | |
| SAGENT PHARMACEUTICALS INC | 786692103 | COM | 380,188 | $8,885,000 | thousands by filing date | |
| POZEN INC | 73941U102 | COMMON STOCK | 1,083,087 | $8,665,000 | thousands by filing date | |
| IGI LABORATORIES INC | 449575109 | COM | 1,500,000 | $8,475,000 | thousands by filing date | |
| ANTARES PHARMA INC | 036642106 | COM | 2,300,000 | $8,050,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 1,050,000 | $6,962,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 510,500 | $6,499,000 | thousands by filing date | |
| UNIVERSAL AMERN CORP NEW | 91338E101 | COM | 881,605 | $6,233,000 | thousands by filing date | |
| DURECT CORP | 266605104 | COM | 4,404,495 | $5,858,000 | thousands by filing date | |
| OXYGEN BIOTHERAPEUTICS INC | 69207P308 | COM PAR $0.0001 | 992,857 | $5,510,000 | thousands by filing date | |
| AIR METHODS CORP | 009128307 | COM PAR $.06 | 100,000 | $5,343,000 | thousands by filing date | |
| IGNYTA INC | 451731103 | COM | 641,700 | $5,326,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 254,068 | $5,247,000 | thousands by filing date | |
| TONIX PHARMACEUTICALS HOLDING | 890260201 | COM NEW | 467,639 | $4,868,000 | thousands by filing date | |
| RXI PHARMACEUTICALS CORP NEW | 74979C303 | COM NEW | 1,126,482 | $4,810,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 600,000 | $4,716,000 | thousands by filing date | |
| DIPEXIUM PHARMACEUTICALS INC | 25456J104 | COM | 459,800 | $4,635,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 630,000 | $4,612,000 | thousands by filing date | |
| QLT INC | 746927102 | COMMON STOCK | 784,893 | $4,364,000 | thousands by filing date | |
| THORATEC CORP | 885175307 | COM | 121,867 | $4,364,000 | thousands by filing date | |
| FLEXION THERAPEUTICS INC | 33938J106 | COM | 263,204 | $4,330,000 | thousands by filing date | |
| PAIN THERAPEUTICS INC | 69562K100 | COM | 780,000 | $4,290,000 | thousands by filing date | |
| INOVIO PHARMACEUTICALS I | 45773H102 | COM | 1,250,000 | $4,163,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 224,234 | $4,077,000 | thousands by filing date | |
| BIOTA PHARMACEUTIALS INC | 090694100 | COM | 636,700 | $3,890,000 | thousands by filing date | |
| REDHILL BIOPHARMA LTD | 757468103 | ADR | 263,160 | $3,708,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 151,655 | $3,644,000 | thousands by filing date | |
| BIODEL INC | 09064M204 | COM | 1,330,034 | $3,631,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 300,000 | $3,621,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 184,756 | $3,523,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 1,055,000 | $3,344,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 1,000,000 | $3,290,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 300,000 | $3,240,000 | thousands by filing date | |
| CAS MED SYS INC | 124769209 | COM | 1,424,796 | $3,092,000 | thousands by filing date | |
| CELSUS THERAPEUTICS PLC | 15119A202 | COM | 470,877 | $3,056,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 100,000 | $3,015,000 | thousands by filing date | |
| MELA SCIENCES INC | 55277R100 | COM | 4,000 | $2,967,000 | thousands by filing date | Value about 1,000 times the price other filers imply, kept as filed and left out of ratios. |
| THERAPEUTICSMD INC | 88338N107 | COM | 458,859 | $2,895,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 200,000 | $2,690,000 | thousands by filing date | |
| VOCERA COMMUNICATIONS INC | 92857F107 | COMMON STOCK | 160,597 | $2,623,000 | thousands by filing date | |
| ANTHERA PHARMACEUTCLS INC | 03674U201 | Common equity shares | 766,329 | $2,567,000 | thousands by filing date | |
| CUTERA INC | 232109108 | COM | 215,962 | $2,417,000 | thousands by filing date | |
| ACELRX PHARMACEUTICALS INC | 00444T100 | COM | 200,000 | $2,402,000 | thousands by filing date | |
| NANOSPHERE INC | 63009F105 | COM | 1,000,000 | $2,150,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,000,000 | $1,810,000 | thousands by filing date | |
| CARDIOME PHARMA CORP | 14159U301 | COM NO PAR | 200,000 | $1,582,000 | thousands by filing date | |
| BIOSCRIP INC | 09069N108 | COM | 220,000 | $1,536,000 | thousands by filing date | |
| DIGIRAD CORP | 253827109 | COM | 332,480 | $1,140,000 | thousands by filing date | |
| CARDICA INC | 14141R101 | COM | 640,346 | $641,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-14-003378 | this filing | 2014-05-15 | acceptance time not in the bulk data set |